Page last updated: 2024-09-04

carbapenems and oxacillin

carbapenems has been researched along with oxacillin in 13 studies

Compound Research Comparison

Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010)
(carbapenems)
Studies
(oxacillin)
Trials
(oxacillin)
Recent Studies (post-2010) (oxacillin)
7,3551475,2772,85474610

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (7.69)18.2507
2000's4 (30.77)29.6817
2010's4 (30.77)24.3611
2020's4 (30.77)2.80

Authors

AuthorsStudies
Eliasson, I; Erlandsson, CM; Hanberger, H; Hoffmann, M; Isaksson, B; Lindgren, S; Nilsson, LE; Sörén, L; Walther, SM1
Moland, ES; Thomson, KS1
Fritsche, TR; Janechek, MJ; Jones, RN; Sader, HS1
Appelbaum, PC; Glupczynski, Y; Lemaire, S; Olivier, A; Tulkens, PM; Van Bambeke, F1
Higgins, PG; Lehmann, M; Nordmann, P; Poirel, L; Seifert, H1
Nordmann, P1
Ferreira, TP; Gobbi, DD; Hofer, E; Matté, GR; Matté, MH; Moreno, AM; Moreno, LZ; Paixão, R; Raimundo, DC; Reis, CM1
Bou, G; Calvo, J; Cano, ME; Cayô, R; Martínez-Martínez, L; Merino, M; Ruiz Del Castillo, B1
Antunes, VU; Doucet, N; Farah, CS; Favaro, DC; Lincopan, N; Llontop, EE; López de Los Santos, Y; Mittermaier, A; Oliveira, RJ; Vasconcelos, FNDC1
Baurain, D; Frère, JM; Galleni, M; Joris, B; Kerff, F; Lupo, V; Mercuri, PS1
Chibabhai, V; Nana, T; Perovic, O1
Grafl, B; Hess, C; Hess, M; Maegdefrau, M1
Allel, K; Day, L; Furuya-Kanamori, L; Hamilton, A; Laxminarayan, R; Lin, L; Moore, CE; Van Boeckel, T; Yakob, L1

Reviews

1 review(s) available for carbapenems and oxacillin

ArticleYear
[Gram-negative bacteriae with resistance to carbapenems].
    Medecine sciences : M/S, 2010, Volume: 26, Issue:11

    Topics: beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Oxacillin

2010

Other Studies

12 other study(ies) available for carbapenems and oxacillin

ArticleYear
Surveillance of antibiotic resistance in ICUs in southeastern Sweden. ICU Study Group of the South East of Sweden.
    Acta anaesthesiologica Scandinavica, 1999, Volume: 43, Issue:8

    Topics: Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; APACHE; Bacteria; Carbapenems; Cefotaxime; Cephalosporins; Ciprofloxacin; Critical Care; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecalis; Enterococcus faecium; Escherichia coli; Fusidic Acid; Gentamicins; Humans; Netilmicin; Oxacillin; Penicillin Resistance; Penicillins; Population Surveillance; Prevalence; Staphylococcus; Sweden

1999
CS-023 (R-115685), a novel carbapenem with enhanced in vitro activity against oxacillin-resistant staphylococci and Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:2

    Topics: Anti-Infective Agents; Bacterial Infections; Carbapenems; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Staphylococcus; United States

2004
Selection of a surrogate beta-lactam testing agent for initial susceptibility testing of doripenem, a new carbapenem.
    Diagnostic microbiology and infectious disease, 2007, Volume: 59, Issue:4

    Topics: Anti-Bacterial Agents; Biomarkers; Carbapenems; Doripenem; Drug Approval; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxacillin; United States; United States Food and Drug Administration

2007
Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefepime; Cefuroxime; Cell Line; Cells, Cultured; Cephalosporins; Cloxacillin; Humans; Hydrogen-Ion Concentration; Imipenem; Meropenem; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Phagocytosis; Staphylococcus aureus; Thienamycins

2008
OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Imipenem; Meropenem; Molecular Sequence Data; Oxacillin; Penicillins; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Thienamycins

2009
Characterization of antibiotic resistance in Listeria spp. isolated from slaughterhouse environments, pork and human infections.
    Journal of infection in developing countries, 2014, Apr-15, Volume: 8, Issue:4

    Topics: Abattoirs; Ampicillin; Animals; Anti-Bacterial Agents; Carbapenems; Clindamycin; Daptomycin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Humans; Listeria; Microbial Sensitivity Tests; Oxacillin; Swine; Tetracycline

2014
OXA-207, a novel OXA-24 variant with reduced catalytic efficiency against carbapenems in Acinetobacter pittii from Spain.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8

    Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Binding Sites; Carbapenems; Cloning, Molecular; Drug Resistance, Bacterial; Gene Expression; Humans; Integrases; Isoenzymes; Microbial Sensitivity Tests; Molecular Sequence Data; Oxacillin; Recombination, Genetic; Sequence Alignment; Spain

2014
Importance of the β5-β6 Loop for the Structure, Catalytic Efficiency, and Stability of Carbapenem-Hydrolyzing Class D β-Lactamase Subfamily OXA-143.
    Biochemistry, 2019, 08-27, Volume: 58, Issue:34

    Topics: Acinetobacter baumannii; Ampicillin; Aztreonam; beta-Lactamases; Carbapenems; Ceftazidime; Hydrolysis; Kinetics; Models, Molecular; Molecular Dynamics Simulation; Mutation, Missense; Oxacillin; Protein Conformation, beta-Strand; Protein Stability; Substrate Specificity

2019
An Extended Reservoir of Class-D Beta-Lactamases in Non-Clinical Bacterial Strains.
    Microbiology spectrum, 2022, 04-27, Volume: 10, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests; Oxacillin; Phylogeny

2022
Comparison of carbapenem minimum inhibitory concentrations of Oxacillin-48-like Klebsiella pneumoniae by Sensititre, Vitek 2, MicroScan, and Etest.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022, Volume: 28, Issue:12

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; Ertapenem; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Oxacillin

2022
    Avian diseases, 2022, Volume: 66, Issue:3

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Chloramphenicol; Colistin; Drug Resistance, Multiple; Enrofloxacin; Flavobacteriaceae Infections; Nalidixic Acid; Ornithobacterium; Oxacillin; Poultry Diseases; Tetracyclines; Turkeys; Tylosin

2022
Global antimicrobial-resistance drivers: an ecological country-level study at the human-animal interface.
    The Lancet. Planetary health, 2023, Volume: 7, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Cattle; Cephalosporins; Chickens; Drug Resistance, Bacterial; Escherichia coli; Humans; Methicillin-Resistant Staphylococcus aureus; Oxacillin; Swine

2023